Celgene buys Impact Biomedicines in deal that could reach $7 billion
January 08, 2018 at 09:34 AM EST
The Summit, New Jersey-based company offers to buy the San Diego blood-disease biotechnology company.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|